Literature DB >> 21687828

Compound adaptive GPU design for clinical trials.

Ao Yuan1, Paul Bezandry, George Bonney.   

Abstract

In clinical trials, several competing treatments are often carried out in the same trial period. The goal is to assess the performances of these different treatments according to some optimality criterion and minimize risks to the patients in the entire process of the study. For this, each coming patient is allocated sequentially to one of the treatments according to a mechanism defined by the optimality criterion. In practice, sometimes different optimality criteria, or the same criterion with different regimes, need to be considered to assess the treatments in the same study, so that each mechanism is also evaluated through the trail study. In this case, the question is how to allocate the treatments to the incoming patients so that the criteria/mechanisms of interest are assessed during the trail process, and the overall performance of the trial is optimized under the combined criteria or regimes. In this paper, we consider this problem by investigating a compound adaptive generalized Pólya urn design. Basic asymptotic properties of this design are also studied.

Entities:  

Year:  2010        PMID: 21687828      PMCID: PMC3115734          DOI: 10.1016/j.jspi.2010.05.022

Source DB:  PubMed          Journal:  J Stat Plan Inference        ISSN: 0378-3758            Impact factor:   1.111


  2 in total

1.  Optimal adaptive designs for binary response trials.

Authors:  W F Rosenberger; N Stallard; A Ivanova; C N Harper; M L Ricks
Journal:  Biometrics       Date:  2001-09       Impact factor: 2.571

Review 2.  The use of response-adaptive designs in clinical trials.

Authors:  W F Rosenberger; J M Lachin
Journal:  Control Clin Trials       Date:  1993-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.